Systemic Effect of Metformin on Bone Healing at Bone Defect in Rabbits Using Radiographical and Serum Alkaline Phosphatase Assessment

N.A.

Makale detayları

Systemic Effect of Metformin on Bone Healing at Bone Defect in Rabbits Using Radiographical and Serum Alkaline Phosphatase Assessment

Yazarlar:

N.A.

Yayıncı:

Ataturk University

Ana Başlıklar:

Veteriner Bilimleri

Dergi:

Veterinary Sciences and Practices Vol.17 Issue 3, pp.91-97

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

Türkçe

Document ID (Org No.):

2001282150

pISSN:

2822-3608

Anahtar kelimeler:

Özet:

 Clinical therapy for disorders of bone healing present serious challenges. The delivery of the bone filling materials necessitates surgical implantation at the fracture site, which could lead to local complications. As a result, taking osteogenic medications will offer a great way to heal bone lesions. Increased osteoblasts and decreased osteoclasts are 2 ways that metformin has an osteogenic impact. The aim of the study is to determine the systemic impact of metformin on bone healing at the site of a bony defect using radiographic and serum alkaline phosphatase testing. A total of 20 mature male rabbits, divided into 2 groups of 10 each for the treatment group and the control group, were utilized. All rabbits underwent identical surgical procedures under general anesthesia. Two holes that were 3 mm in diameter and 3 mm deep were created and left empty after the femur has been surgically exposed. The study was conducted over 28 days. The rabbits in the treatment group received 50 mgkg of metformin orally daily for 28 days. The animals were sacrificed at 2 different time points, according to their groups, on the 14th and 28th day after surgery. Bone samples from the defect site of the femur were isolated, sectioned, assessed radiographically, and blood was drawn for serum alkaline phosphatase measurement. There was an increase in bone mineral density and osseointegration. In addition, serum alkaline phosphatase increased in the animals of the group treated with metformin than in the control group at both study time periods. Metformin increases bone healing and regeneration at the bone defect sites and enhances the process of osteogenesis and osseointegration more than the control untreated rabbits.

 Clinical therapy for disorders of bone healing present serious challenges. The delivery of the bone filling materials necessitates surgical implantation at the fracture site, which could lead to local complications. As a result, taking osteogenic medications will offer a great way to heal bone lesions. Increased osteoblasts and decreased osteoclasts are 2 ways that metformin has an osteogenic impact. The aim of the study is to determine the systemic impact of metformin on bone healing at the site of a bony defect using radiographic and serum alkaline phosphatase testing. A total of 20 mature male rabbits, divided into 2 groups of 10 each for the treatment group and the control group, were utilized. All rabbits underwent identical surgical procedures under general anesthesia. Two holes that were 3 mm in diameter and 3 mm deep were created and left empty after the femur has been surgically exposed. The study was conducted over 28 days. The rabbits in the treatment group received 50 mgkg of metformin orally daily for 28 days. The animals were sacrificed at 2 different time points, according to their groups, on the 14th and 28th day after surgery. Bone samples from the defect site of the femur were isolated, sectioned, assessed radiographically, and blood was drawn for serum alkaline phosphatase measurement. There was an increase in bone mineral density and osseointegration. In addition, serum alkaline phosphatase increased in the animals of the group treated with metformin than in the control group at both study time periods. Metformin increases bone healing and regeneration at the bone defect sites and enhances the process of osteogenesis and osseointegration more than the control untreated rabbits.

 Clinical therapy for disorders of bone healing present serious challenges. The delivery of the bone filling materials necessitates surgical implantation at the fracture site, which could lead to local complications. As a result, taking osteogenic medications will offer a great way to heal bone lesions. Increased osteoblasts and decreased osteoclasts are 2 ways that metformin has an osteogenic impact. The aim of the study is to determine the systemic impact of metformin on bone healing at the site of a bony defect using radiographic and serum alkaline phosphatase testing. A total of 20 mature male rabbits, divided into 2 groups of 10 each for the treatment group and the control group, were utilized. All rabbits underwent identical surgical procedures under general anesthesia. Two holes that were 3 mm in diameter and 3 mm deep were created and left empty after the femur has been surgically exposed. The study was conducted over 28 days. The rabbits in the treatment group received 50 mgkg of metformin orally daily for 28 days. The animals were sacrificed at 2 different time points, according to their groups, on the 14th and 28th day after surgery. Bone samples from the defect site of the femur were isolated, sectioned, assessed radiographically, and blood was drawn for serum alkaline phosphatase measurement. There was an increase in bone mineral density and osseointegration. In addition, serum alkaline phosphatase increased in the animals of the group treated with metformin than in the control group at both study time periods. Metformin increases bone healing and regeneration at the bone defect sites and enhances the process of osteogenesis and osseointegration more than the control untreated rabbits.

 Kemik iyileşme bozukluklarının klinik tedavisi ciddi zorluklar barındırır. Ancak, kemik dolgu malzemelerinin uygulanması yaralanma yerinde cerrahi implantasyon gerektirir, bu da yerel komplikasyonlara yol açabilir. Bu nedenle, osteojenik ilaçları almak kemik lezyonlarının iyileşmesine yardımcı olacaktır. Artan osteoblast ve azalan osteoklastlar metforminin osteojenik etkisini temsil eden iki yoldur. Çalışmanın amacı, metformin uygulamasının kemik defekti bölgesinde kemik iyileşmesi üzerindeki sistemik etkisini radyografik ve serum alkalin fosfataz testleri kullanarak belirlemektir. Çalışmada, toplam 20 yetişkin erkek tavşan onarlı iki gruba bölünerek kullanılmıştır. Tavşanların tamamı genel anestezi altında aynı cerrahi prosedüre maruz kaldılar. Femur cerrahi olarak ekspoze edildikten sonra üzerine 3 mm çapında ve 3 mm derinliğinde iki delik açıldı ve delikler boş bırakıldı. Çalışma 28 gün sürdü. Çalışma grubundaki tavşanlar, operasyonun ardından 28 gün boyunca günde 50 mgkg oral metformin aldı. Hayvanlar araştırmadaki numaralarına ve gruplarına göre iki farklı zaman aralığında, operasyondan sonraki 14üncü ve 28inci günlerde sakrifiye edildiler. Femur defekt bölgesinden alınan kemik örnekleri, ayrıştırıldı, kesildi, radyografik olarak değerlendirildi ve serum alkalin fosfataz ölçümü için kan alındı. Metformin alan hayvanların kontrol grubuna kıyasla çalışma zamanlarının her ikisinde de kemik mineral yoğunluğu ve osseointegrasyon artışı olduğunu ve ayrıca serum alkalin fosfataz artışı olduğunu göstermiştir. Sonuç olarak, metformin, kontrol grubunda tedavi uygulanmayan tavşanlara kıyasla kemik defekti bölgesinde kemik iyileşmesini ve yenilenmesini artırmakta ve osteogenezis ve osseointegrasyon sürecini daha fazla güçlendirmektedir.

Makale detayları

Systemic Effect of Metformin on Bone Healing at Bone Defect in Rabbits Using Radiographical and Serum Alkaline Phosphatase Assessment

Yazarlar:

N.A.

Yayıncı:

Ataturk University

Ana Başlıklar:

Veteriner Bilimleri

Dergi:

Veterinary Sciences and Practices Vol.17 Issue 3, pp.91-97

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

Türkçe

Document ID (Org No.):

2001282150

pISSN:

2822-3608

Metformin

BMD

serum alkalin fosfataz

kemik iyileşmesi

kemik defekti

Metformin

BMD

serum alkalin fosfataz

kemik iyileşmesi

kemik defekti

Sayı

Makale detayları

Yazarlar: N.A.

Yayıncı: Ataturk University

Ana Başlıklar: Veteriner Bilimleri

Dergi: Veterinary Sciences and Practices Vol.17 Issue 3, pp.91-97

Belge Tipi: Makale

Yayın Tarihi: 6/2023

Belge Dili: Türkçe

Document ID (Org No.): 2001282150

pISSN: 2822-3608

Sayı

Yazarlar:

N.A.

Yayıncı:

Ataturk University

Ana Başlıklar:

Veteriner Bilimleri

Dergi:

Veterinary Sciences and Practices Vol.17 Issue 3, pp.91-97

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

Türkçe

Document ID (Org No.):

2001282150

pISSN:

2822-3608